|
PDGFC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.995000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.619700E-02 |
| Normal-vs-Stage2 |
5.961800E-01 |
| Normal-vs-Stage3 |
3.971000E-01 |
| Normal-vs-Stage4 |
6.445000E-01 |
| Stage1-vs-Stage2 |
4.636000E-02 |
| Stage1-vs-Stage3 |
3.262100E-02 |
| Stage1-vs-Stage4 |
7.870000E-02 |
| Stage2-vs-Stage3 |
8.030000E-01 |
| Stage2-vs-Stage4 |
9.422000E-01 |
| Stage3-vs-Stage4 |
7.396800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.967600E-01 |
| Normal-vs-AfricanAmerican |
5.489600E-01 |
| Normal-vs-Asian |
1.932550E-01 |
| Caucasian-vs-AfricanAmerican |
5.142200E-01 |
| Caucasian-vs-Asian |
1.924750E-01 |
| AfricanAmerican-vs-Asian |
2.214200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.135000E-01 |
| Normal-vs-Female |
4.939200E-01 |
| Male-vs-Female |
4.973000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.599600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.306800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.473400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.652150E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.417400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.085600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.063230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.380000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.144500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.543300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.210200E-02 |
| Normal-vs-Grade 2 |
5.879900E-02 |
| Normal-vs-Grade 3 |
8.038400E-02 |
| Normal-vs-Grade 4 |
9.407400E-01 |
| Grade 1-vs-Grade 2 |
4.498000E-01 |
| Grade 1-vs-Grade 3 |
7.616500E-03 |
| Grade 1-vs-Grade 4 |
2.163000E-01 |
| Grade 2-vs-Grade 3 |
3.44119999995396E-06 |
| Grade 2-vs-Grade 4 |
3.930200E-01 |
| Grade 3-vs-Grade 4 |
3.447400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.977000E-01 |
| Normal-vs-ccB subtype |
7.975600E-01 |
| ccA subtype-vs-ccB subtype |
4.127800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.701200E-01 |
| Normal-vs-N1 |
3.255000E-01 |
| N0-vs-N1 |
3.136400E-01 |
|
|
